Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Breast: Page 106
Trust whole-breast US for supplemental breast cancer screening
By
Kate Madden Yee
Wednesday, December 4 | 11:50 a.m.-12:00 p.m. | SSK02-09 | Room E450AWhole-breast ultrasound performed by a technologist is an effective way to provide adjuvant screening to women with dense breast tissue, according to research to be presented on Wednesday morning.
November 4, 2019
Screening frequency key influence on recall rates
By
Kate Madden Yee
Wednesday, December 4 | 11:20 a.m.-11:30 a.m. | SSK01-06 | Room E451BIn this session, researchers will share how age and race strongly influence breast cancer screening recall rates, but screening frequency and modality have greater impact.
November 4, 2019
Does DBT find more interval cancers?
By
Kate Madden Yee
Wednesday, December 4 | 10:30 a.m.-10:40 a.m. | SSK01-01 | Room E451BDigital breast tomosynthesis (DBT) finds more breast cancers on screening, but it doesn't necessarily find more interval cancers, according to Norwegian researchers.
November 4, 2019
How suitable is CESM as a breast MRI alternative?
By
Kate Madden Yee
Tuesday, December 3 | 10:40 a.m.-10:50 a.m. | SSG01-02 | Room S102CDAt this Tuesday morning session, German researchers will explore how suitable contrast-enhanced spectral mammography (CESM) is as an alternative to MRI for breast cancer screening.
November 4, 2019
Breast ultrasound helpful supplement even after DBT
By
Kate Madden Yee
Monday, December 2 | 3:50 p.m.-4:00 p.m. | SSE02-06 | Room E451BIn this session, University of Pittsburgh researchers will discuss how whole-breast ultrasound performed by a technologist can find more cancers in women with dense breast tissue even after screening digital breast tomosynthesis (DBT) -- although it does increase the recall rate.
November 4, 2019
Higher parenchymal uptake on MBI may predict higher cancer risk
By
Kate Madden Yee
Monday, December 2 | 3:30 p.m.-3:40 p.m. | SSE01-04 | Room E450AThe level of background parenchymal uptake on molecular breast imaging (MBI) can help predict future breast cancer risk in postmenopausal women, Mayo Clinic researchers have found.
November 4, 2019
Breast ultrasound useful for average-risk women
By
Kate Madden Yee
Monday, December 2 | 3:10 p.m.-3:20 p.m. | SSE02-02 | Room E451BIn this scientific session, researchers will discuss how screening breast ultrasound is a useful supplement to mammography in women at average risk of breast cancer, not just those at high risk.
November 4, 2019
MBI lexicon enhances radiologist interpretation
By
Kate Madden Yee
Monday, December 2 | 12:45 p.m.-1:15 p.m. | BR230-SD-MOB1 | Lakeside, BR Community, Station 1Understanding the predictive features of molecular breast imaging (MBI) lexicon descriptors improves radiologist interpretation of these exams and allows for appropriate management and follow-up of patients, according to research to be presented Monday afternoon.
November 4, 2019
Abbreviated breast MRI protocol improves screening outcomes
By
Kate Madden Yee
Monday, December 2 | 9:05 a.m.-9:15 a.m. | RC215-04 | Arie Crown TheaterIn this talk, Canadian researchers will discuss how an abbreviated breast MRI screening protocol in women with a high risk for breast cancer leads to fewer false positives and benign biopsies when compared with a conventional protocol -- and doesn't compromise the cancer detection rate.
November 4, 2019
BI-RADS 3 means biopsy with prior breast cancer history
By
Kate Madden Yee
Sunday, December 1 | 1:00 p.m.-1:30 p.m. | BR259-SD-SUB4 | Lakeside, BR Community, Station 4For women with a prior history of breast cancer, a BI-RADS 3 finding should prompt biopsy, according to research that will be presented on Sunday afternoon in the Lakeside Learning Center.
November 4, 2019
How do BI-RADS 4th, 5th editions compare?
By
Kate Madden Yee
Sunday, December 1 | 12:30 p.m.-1:00 p.m. | BR222-SD-SUA2 | Lakeside, BR Community, Station 2In this poster presentation, researchers from Brigham and Women's Hospital in Boston will compare interreader agreement between the BI-RADS fourth edition guidelines for breast cancer classification and BI-RADS fifth edition guidelines.
November 4, 2019
AI for DBT improves breast cancer detection
By
Kate Madden Yee
Sunday, December 1 | 11:45 a.m.-11:55 a.m. | SSA01-07 | Room S406AWhen radiologists use artificial intelligence (AI) with digital breast tomosynthesis (DBT), their cancer detection performance and efficiency improve, according to data to be presented Sunday morning.
November 4, 2019
Previous Page
Page 106 of 573
Next Page